Modular surgical instrument system
US-2015272557-A1 · Oct 1, 2015 · US
System of surgical staple cartridges comprising absorbable staples
US12539115B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12539115-B2 |
| Application number | US-202217718838-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 12, 2022 |
| Priority date | May 10, 2021 |
| Publication date | Feb 3, 2026 |
| Grant date | Feb 3, 2026 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Staple cartridges including bioabsorbable staples are disclosed. The staples are configured such that they are bioabsorbable within a desired time frame.
First claim
Opening claim text (preview).
What is claimed is: 1 . A staple cartridge, comprising: a deck; an elongate slot; staple cavities defined in said deck; and staples positioned in said staple cavities, wherein said staples are configured to be deployed into a tissue environment, wherein said staples are comprised of a magnesium-based alloy, and wherein said magnesium-based alloy is selected such that said staples bio-corrode in said tissue environment within a predetermined bio-corrosion timeframe, wherein said staples comprise a coating, the coating configured to tune a rate of bio-corrosion of the staples to meet the predetermined bio-corrosion timeframe based on a mechanism of action, by balancing an increase of the rate of bio-corrosion caused by the magnesium-based alloy and a decrease of the rate of bio-corrosion caused by a calcification. 2 . The staple cartridge of claim 1 , wherein said coating is applied at manufacture. 3 . The staple cartridge of claim 1 , wherein said staples are configured to be coated after said staples have been deployed into the tissue environment. 4 . The staple cartridge of claim 1 , wherein said coating is further configured to trap ions. 5 . The staple cartridge of claim 1 , wherein said coating is further configured to inhibit onset of oxidation. 6 . The staple cartridge of claim 1 , wherein said coating is further configured to divert deposition therefrom. 7 . The staple cartridge of claim 1 , wherein said coating is further configured to capture deposition thereon. 8 . The staple cartridge of claim 1 , wherein said mechanism of action comprises at least one of oxidation, hydrolysis, galvanic corrosion, a replacement reaction between magnesium and hydrochloric acid, or stress corrosion, and tuning the rate of bio-corrosion comprising at least one of increase, decease, or reserve the rate of bio-corrosion of the staples. 9 . A staple cartridge, comprising: a deck; an elongate slot; staple cavities defined in said deck; and staples positioned in said staple cavities, wherein said staples are configured to be deployed into a tissue environment, wherein said staples are comprised of a zinc-based alloy, and wherein said zinc-based alloy is selected such that said staples bio-corrode in said tissue environment within a predetermined bio-corrosion timeframe, wherein said staples comprise a coating, the coating configured to tune a rate of bio-corrosion of the staples to meet the predetermined bio-corrosion timeframe based on a mechanism of action, by balancing an increase of the rate of bio-corrosion caused by the zinc-based alloy and a decrease of the rate of bio-corrosion caused by a calcification. 10 . The staple cartridge of claim 9 , wherein said coating is applied at manufacture. 11 . The staple cartridge of claim 9 , wherein said staples are configured to be coated after said staples have been deployed into the tissue environment. 12 . The staple cartridge of claim 9 , wherein said coating is further configured to trap ions. 13 . The staple cartridge of claim 9 , wherein said coating is further configured to inhibit onset of oxidation. 14 . The staple cartridge of claim 9 , wherein said coating is further configured to divert deposition therefrom. 15 . The staple cartridge of claim 9 , wherein said coating is further configured to capture deposition thereon. 16 . The staple cartridge of claim 9 , wherein said mechanism of action comprises at least one of oxidation, hydrolysis, galvanic corrosion, a replacement reaction between magnesium and hydrochloric acid, or stress corrosion, and tuning the rate of bio-corrosion comprising at least one of increase, decease, or reserve the rate of bio-corrosion of the staples. 17 . A staple cartridge, comprising: a deck; an elongate slot; staple cavities defined in said deck; and staples positioned in said staple cavities, wherein said staples are configured to be deployed into a tissue environment, wherein said staples are comprised of an iron-based alloy, and wherein said iron-based alloy is selected such that said staples bio-corrode in said tissue environment within a predetermined bio-corrosion timeframe, wherein said staples comprise a coating, the coating configured to tune a rate of bio-corrosion of the staples to meet the predetermined bio-corrosion timeframe based on a mechanism of action, by balancing an increase of the rate of bio-corrosion caused by the iron-based alloy and a decrease of the rate of bio-corrosion caused by a calcification. 18 . The staple cartridge of claim 17 , wherein said coating is applied at manufacture. 19 . The staple cartridge of claim 17 , wherein said staples are configured to be coated after said staples have been deployed into the tissue environment. 20 . The staple cartridge of claim 17 , wherein said coating is further configured to trap ions. 21 . The staple cartridge of claim 17 , wherein said coating is further configured to inhibit onset of oxidation. 22 . The staple cartridge of claim 17 , wherein said coating is further configured to divert deposition therefrom. 23 . The staple cartridge of claim 17 , wherein said coating is further configured to capture deposition thereon. 24 . The staple cartridge of claim 17 , wherein said mechanism of action comprises at least one of oxidation, hydrolysis, galvanic corrosion, a replacement reaction between magnesium and hydrochloric acid, or stress corrosion, and tuning the rate of bio-corrosion comprising at least one of increase, decease, or reserve the rate of bio-corrosion of the staples.
Assignees
Inventors
Classifications
Indication means · CPC title
containing desiccant means, e.g. desiccant pouches · CPC title
characterised by its cutter · CPC title
characterised by its sled or its staple holder · CPC title
characterised by its cartridge · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12539115B2 cover?
- Staple cartridges including bioabsorbable staples are disclosed. The staples are configured such that they are bioabsorbable within a desired time frame.
- Who is the assignee on this patent?
- Cilag Gmbh Int
- What technology area does this patent fall under?
- Primary CPC classification A61B17/0644. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).